발톱백선에서 항진균제 치료 후 진균학적 검사 결과
Mycological Results after Antifungal Treatment of Toenail Dermatophytosis
1
조회
0
다운로드
0
인용
0
참고문헌
초록
Abstract
Backgrounds: Toenail dermatophytosis is a common disease caused by dermatophytes. As it may cause not only a cosmetic disfigurement but also the physical, psychological, and social limitations, the need for the treatment has been increased. Recently, itraconazole and terbinafine have been popularly used with less serious side effects than before. Objective: We performed a retrospective study to observe the mycological results of antifungal therapy after the treatment of toenail dermatophytosis for 12 weeks. Method: The study population consisted of 169 patients with toenail dermatophytosis in Catholic Skin Clinic from June, 2003 to October, 2005. Results: Threre was no significant difference in mycological cure rate between the oral itraconazole group and the oral terbinafine group (52.2% vs 52.0%; p=0.985). Mycological cure rate of the oral terbinafine with 5% amorolfine nail lacquer group was insignificantly higher than that of the oral itraconazole with 5% amorolfine nail lacquer group (55.6% vs 40.6%; p=0.309). There were no significant difference between the different age groups, sexes, and cultured organisms. Conclusion: In toenail dermatophytosis, both of the oral itraconazole therapy and the oral terbinafine therapy are very effective and there was no significant difference in the mycological results after the 12 weeks therapy of toenail dermatophytosis.
참고문헌 (14)
- "Prevalence of dermatophyte onychomycosis in the United Kingdom results of an omnibus survey", pp.39 23~27
- "Assessment of quality of life in patient with toenail onychomycosis in Korea", 3, pp.115~124 (1998)
- "Onychomycosis:a significant medical disorder", 35, pp.2~5 (1996)
- "How often does oral treatment of toenail onychomycosis produce a disease-free nail? An anaylysis of published data", 134, pp.1551~1554 (1998)
- "Amorolfine itraconazole combination for severe toenail onychomycosis results of an open randomized trial in Spain", 145, pp.21~26 (2001)
- "Experience of combination treatment of toenail onychomycosis with oral itraconazole and topical 5% amorolfine nail lacquer", 9, pp.165~169
- "A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region", 142, pp.1177~1183 (2000)
- "The future of onychomycosis therapy may involve a combination of approaches", 145, pp.3~8 (2001)
- "Onychomycosis:therapeutic update", 40, pp.21~26 (1999)
- "Superficial fungal infections: dermatophytosis, onychomycosis, tinea nigra, piedra", pp.1989~2005, McGraw-Hill
- "Piraccini BM. Onychomycosis: the current approach to diagnosis and therapy", 1999, pp.6~9 (1999), Martin Dunitz Ltd
- "Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes:a double-blind comparative trial of terbinafine 250 mg", day versus itraconazole 200 mg, pp.1998, 38[DOI]
- "German randomized double-blind multicentre comparison of terbinafine and itraconazole for the treatment of toenail tinea infection", 134, pp.18~21 (1996)
- "Open randomized comparison of itraconazole versus terbinafine in onychomycosis", 34, pp.138~143 (1995)